Related Experiment Video
Updated: Feb 26, 2026

09:32
Protocols for Testing the Toxicity of Novel Insecticidal Chemistries to Mosquitoes
Published on: February 13, 2019
16.4K
Community effectiveness of pyriproxyfen as a dengue vector control method: A systematic review
Dorit Maoz1,2, Tara Ward3, Moody Samuel4
1Department of Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Plos Neglected Tropical Diseases
|July 18, 2017
Summary
Pyriproxyfen effectively reduces immature Aedes mosquitoes, a key dengue vector. However, evidence for reducing human dengue cases remains limited, requiring further research for routine vector control programs.
Area of Science:
- Medical Entomology
- Public Health
- Vector-Borne Disease Control
Background:
- Dengue prevention relies on vector control, with pyriproxyfen showing promise.
- The autodissemination method using pyriproxyfen can reach difficult breeding sites.
- Pyriproxyfen mimics juvenile hormones, aiding insecticide resistance management in Aedes vectors.
Purpose of the Study:
- To systematically review evidence on pyriproxyfen's community effectiveness (CE) for controlling Aedes populations.
- To analyze pyriproxyfen's impact on reducing human dengue transmission.
Main Methods:
- Conducted a systematic literature search across multiple databases (PubMed, Embase, etc.).
- Screened abstracts and assessed study eligibility, extracting relevant data.
- Classified pyriproxyfen applications into container treatment, fumigation, auto-dissemination, or combination treatments.
Main Results:
- Pyriproxyfen effectively reduced immature Aedes mosquitoes across various application methods.
- Combining pyriproxyfen with other products enhanced efficacy and persistence, potentially slowing resistance.
- Evidence for area-wide ultra-low volume treatments is lacking; community participation effectiveness varied.
Conclusions:
- Pyriproxyfen effectively controls immature and adult dengue mosquitoes.
- Weak evidence exists for pyriproxyfen's ability to reduce human dengue cases.
- Further large-scale studies are needed, and pyriproxyfen resistance requires investigation.

